Adamis Pharmaceuticals Corp. buy Langfinger
Start price
23.01.21
/
0%
€105.00
Target price
23.01.22
-
Performance (%)
-46.33%
End price
19.11.21
€56.35
Summary
This prediction ended on 19.11.21 with a price of €56.35. Massive losses of -46.33% were the result for the BUY prediction by Langfinger. This prediction was marked as speculative and is excluded from Langfinger's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Adamis Pharmaceuticals Corp. | - | - | - | - |
iShares Core DAX® | -0.116% | 1.953% | 14.155% | 16.268% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% | 43.377% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% | 8.501% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% | 41.752% |
Comments by Langfinger for this prediction
In the thread Adamis Pharmaceuticals Corp diskutieren
Buy Adamis Pharmaceuticals Corp